Association between quality metric adherence and overall survival among patients undergoing resection of pancreatic ductal adenocarcinoma

被引:0
|
作者
Munir, Muhammad Musaab [1 ]
Rashid, Zayed [1 ]
Endo, Yutaka [1 ]
Dillhoff, Mary [1 ]
Tsai, Susan [1 ]
Pawlik, Timothy M. [1 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Dept Surg, 395 W 12th Ave,Suite 670, Columbus, OH 43210 USA
关键词
LENGTH-OF-STAY; CANCER CARE; PANCREATICODUODENECTOMY;
D O I
10.1016/j.surg.2024.04.043
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Process-based quality metrics are important for improving long-term outcomes after surgical resection. We sought to develop a practical surgical quality score for patients diagnosed with pancreatic ductal adenocarcinoma undergoing curative-intent resection. Methods: Patients who underwent surgical resection for pancreatic ductal adenocarcinoma between 2010 and 2017 were identified using the National Cancer Database. Five surgical quality metrics were defined: minimally invasive approach, adequate lymphadenectomy, negative surgical margins, receipt of adjuvant therapy, and no prolonged hospitalization. Log-rank test and multivariable Cox regression analysis were used to determine the association of quality metrics with overall survival. Results: A total of 38,228 patients underwent curative-intent resection for pancreatic ductal adenocarcinoma. Median age at diagnosis was 68 years (interquartile range = 61-75), and roughly half the cohort was male (n = 19,562; 51.2%). Quality metrics were achieved on a varied basis: minimally invasive approach (n = 5,701; 14.9%), adequate lymphadenectomy (n = 27,122; 80.0%), negative surgical margin (n = 29,248; 76.5%), receipt of adjuvant therapy (n = 26,006; 68.0%), and absence of prolonged hospitalization (n = 26,470; 69.2%). An integer-based surgical quality score from 0 (no quality metrics) to 16 (all quality metrics) was calculated. Patients with higher scores had progressively better overall survival. Median overall survival differed substantially among the score categories (score = 0-4 points, 8.7 [8.0-9.6] months; 5-8 points, 17.5 [16.9-18.2] months; 9-12 points, 22.1 [21.6-22.8] months; and 13-16 points, 30.8 [30.2-31.3] months; P < .001). On multivariable analysis, risk-adjusted mortality hazards decreased in a stepwise manner with higher scores (0-4 points: reference; 5-8 points: multivariable adjusted hazard ratio = 0.60; 95% CI, 0.57-0.63; 9-12 points: adjusted hazard ratio = 0.49; 95% CI, 0.47-0.52; 13-16 points: and adjusted hazard ratio = 0.37; 95% CI, 0.34-0.40; all P < .001). Conclusion: Adherence to quality metrics may be associated with improved overall survival. Efforts aimed at increasing compliance with quality metric measures may help optimize long-term outcomes among patients undergoing surgical resection for pancreatic ductal adenocarcinoma. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:873 / 879
页数:7
相关论文
共 50 条
  • [31] Prognostic Impact of Coagulation Activity in Patients Undergoing Curative Resection for Pancreatic Ductal Adenocarcinoma
    Matsumura, Kazuki
    Hayashi, Hiromitsu
    Uemura, Norio
    Zhao, Liu
    Higashi, Takaaki
    Yamao, Takanobu
    Kitamura, Fumimasa
    Nakao, Yusuke
    Yusa, Toshihiko
    Itoyama, Rumi
    Imai, Katsunori
    Yamashita, Yo-Ichi
    Baba, Hideo
    IN VIVO, 2020, 34 (05): : 2845 - 2850
  • [32] Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma
    Sugimoto, Motokazu
    Farnell, Michael B.
    Nagorney, David M.
    Kendrick, Michael L.
    Truty, Mark J.
    Smoot, Rory L.
    Chari, Suresh T.
    Moynagh, Michael R.
    Petersen, Gloria M.
    Carter, Rickey E.
    Takahashi, Naoki
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (05) : 831 - 839
  • [33] Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
    Haoda Chen
    Fanlu Li
    Siyi Zou
    Junjie Xie
    Jun Zhang
    Xiaxing Deng
    Hao Chen
    Baiyong Shen
    World Journal of Surgical Oncology, 19
  • [34] The prognostic relevance of primary tumor location in patients undergoing resection for pancreatic ductal adenocarcinoma
    Ling, Qi
    Xu, Xiao
    Ye, Panpan
    Xie, Haiyang
    Gao, Feng
    Hu, Qichao
    Liu, Zhikun
    Wei, Xuyong
    Roeder, Christian
    Trauzold, Anna
    Kalthoff, Holger
    Zheng, Shusen
    ONCOTARGET, 2017, 8 (09) : 15159 - 15167
  • [35] Reappraisal of overall survival of patients with pancreatic ductal adenocarinoma who underwent surgical resection
    Yamamoto, Tomohisa
    Satoi, Sohei
    Yanagimoto, Hiroaki
    Yamaki, So
    Kosaka, Hisashi
    Kotsuka, Masaya
    Ryota, Hironori
    Michiura, Taku
    Inoue, Kentaro
    Matsui, Yoichi
    CANCER SCIENCE, 2018, 109 : 945 - 945
  • [36] Predicting survival after surgical resection for pancreatic ductal adenocarcinoma
    Moon, HJ
    An, JY
    Heo, JS
    Choi, SH
    Joh, JW
    Kim, YI
    PANCREAS, 2006, 32 (01) : 37 - 43
  • [37] The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma
    Winer, Leah K.
    Dhar, Vikrom K.
    Wima, Koffi
    Morris, Mackenzie C.
    Lee, Tiffany C.
    Shah, Shimul A.
    Ahmad, Syed A.
    Patel, Sameer H.
    JOURNAL OF SURGICAL RESEARCH, 2019, 239 : 60 - 66
  • [38] Area Deprivation and Rurality Impact Overall Survival and Adjuvant Therapy Administration in Patients with Pancreatic Ductal Adenocarcinoma after Surgical Resection
    Pothuri, Vikram
    Kasting, Christina
    Rodriguez, Jorge
    Leigh, Natasha
    Sanford, Dominic E.
    Hawkins, William G.
    Fields, Ryan C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S448 - S449
  • [39] The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy
    Taherian, Mehran
    Katz, Matthew H. G.
    Prakash, Laura R.
    Wei, Dongguang
    Tong, Yi Tat
    Lai, Zongshan
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei D.
    Ikoma, Naruhiko
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene J.
    Maitra, Anirban
    Wang, Huamin
    CANCERS, 2024, 16 (19)
  • [40] The impact of SPARC expression in survival of pancreatic ductal adenocarcinoma patients after curative resection
    Murakawa, Masaaki
    Aoyama, Toru
    Miyagi, Yohei
    Atsumi, Yousuke
    Kazama, Keisuke
    Kobayashi, Satoshi
    Ueno, Makoto
    Morimoto, Manabu
    Yamamoto, Naoto
    Sato, Tsutomu
    Yoshikawa, Takaki
    Rino, Yasushi
    Masuda, Munetaka
    Morinaga, Soichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)